President and CEO Helen Torley sold $2.1M of Halozyme Therapeutics, Inc.

Sold$2,127,250

$42.55Price

50,000Shares

−9%Stake

What HALO did after the filing

Prices for HALO after this filing aren't in yet.

Traded Mon, Apr 5. Filed Mon, Apr 5, 7:51 PM ET, after the close. Not investment advice.